Inactief instrument

Andere talen Theseus Pharmaceuticals, Inc.

Aandelen

THRX

US88369M1018

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Theseus Pharmaceuticals, Inc. Announces Board Resignations	14/02
Theseus Pharmaceuticals Announces Closing of Tender Offer	14/02
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from NASDAQ Composite Index	14/02
Concentra Biosciences, LLC completed the acquisition of Theseus Pharmaceuticals, Inc..	14/02
Theseus Pharmaceuticals, Inc.(NasdaqGS:THRX) dropped from S&P TMI Index	08/02
Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals	30/01
SHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates DSKE, THRX, CONN	11/01
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX	31/12
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX, CONN	27/12
Sector Update: Health Care Stocks Gain in Late Afternoon	22/12
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders	22/12
Sector Update: Health Care Stocks Higher Friday Afternoon	22/12
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right	22/12
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DSKE, KRTX, THRX	22/12
Shareholder Alert: Ademi LLP investigates whether Theseus Pharmaceuticals, Inc. has obtained a Fair Price in its transaction with Concentra	22/12
Sector Update: Health Care Stocks Mixed Premarket Friday	22/12
Theseus Pharmaceuticals to be Acquired by Concentra Biosciences; Shares Rise Pre-Bell	22/12
Theseus Pharmaceuticals, Inc. Announces Employment Termination of Timothy P. Clackson as Chief Executive Officer, Effective December 7, 2023	04/12
Theseus Pharmaceuticals, Inc. Announces Management Changes	04/12
Theseus Pharmaceuticals Receives Acquisition Offers From Foresite, OrbiMed, Concentra Biosciences	27/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Theseus Pharmaceuticals, Inc.

Aandelen

THRX

US88369M1018

Andere talen

Filters